Dr. Uday Saxena is currently “Chief Mentor –in-Residence" and Professor of Translational Research at Dr. Reddy’s Institute of Life Sciences as well as Co-Founder of start-up Biotech Company. He has held Executive and Leadership positions at Parke-Davis in Ann Arbor, AtheroGenics in Atlanta (VP Drug Discovery), Dr. Reddy’s Laboratories (Chief Scientific Officer, US and India) and Kareus Therapeutics (CEO). He lead teams that brought several drug candidates from and idea into the clinic. He has a PhD in Biochemistry from Memorial University and Post-doctoral training at Columbia University. His current research interests are translational product research in metabolic diseases and oncology. His passion is to continue being an entrepreneur having initiated biotech companies in the US and India. He is a well known speaker in International and National platforms and recipient of academic and Industry honors.